| 000 | 01437 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513160612.0 | ||
| 264 | 0 | _c19990322 | |
| 008 | 199903s 0 0 eng d | ||
| 022 | _a0022-3549 | ||
| 024 | 7 |
_a10.1021/js980172i _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFigg, W D | |
| 245 | 0 | 0 |
_aPharmacokinetics of thalidomide in an elderly prostate cancer population. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical sciences _cJan 1999 |
||
| 300 |
_a121-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aSpectrophotometry, Ultraviolet |
| 650 | 0 | 4 |
_aThalidomide _xpharmacokinetics |
| 700 | 1 | _aRaje, S | |
| 700 | 1 | _aBauer, K S | |
| 700 | 1 | _aTompkins, A | |
| 700 | 1 | _aVenzon, D | |
| 700 | 1 | _aBergan, R | |
| 700 | 1 | _aChen, A | |
| 700 | 1 | _aHamilton, M | |
| 700 | 1 | _aPluda, J | |
| 700 | 1 | _aReed, E | |
| 773 | 0 |
_tJournal of pharmaceutical sciences _gvol. 88 _gno. 1 _gp. 121-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/js980172i _zAvailable from publisher's website |
| 999 |
_c9837126 _d9837126 |
||